Apogee Therapeutics
APGE
#4042
Rank
NZ$4.08 B
Marketcap
$71.78
Share price
1.02%
Change (1 day)
17.73%
Change (1 year)

Apogee Therapeutics (APGE) - P/B ratio

P/B ratio as of January 2025 : 3.16

According to Apogee Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Apogee Therapeutics - P/B ratio (from 2023 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-313.55-4.76%
2023-12-313.73
2022-12-31N/A